在患有多发性骨髓瘤的患者中,通过具有高ULK2表达的CD14+单细胞抑制T淋巴细胞

Fengping Peng1,2,3, Zhaoyun Liu4,5,6, Fengjuan Jiang1,2,3

  • 1Department of Hematology, Tianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin, 300052, People's Republic of China.

概括

多发性骨髓瘤 (MM) 骨髓单细胞通过ULK2.2破坏抗原呈现来抑制T淋巴细胞. 抑制ULK2可能会恢复T细胞功能,并提高MM患者的抗癌免疫疗法的疗效.